Who is the father of cellular immunotherapy in Japan? What are his medical achievements?

The father of cellular immunity in Japan is Professor Hiroyuki Abe. Professor Hiroyuki Abe is so acclaimed because of his medical achievements. Professor Hiroyuki Abe, as the father of cellular immunity in Japan, founded the Tokyo Cancer Center in Japan, which is the first specialized hospital in Japan recognized by the Ministry of Labor and Health and Welfare to specialize in the study of cellular immunity**** cancer.

Professor Hiroyuki Abe has studied in the United States, conducted clinical research and ** at Cleveland Hospital, Hahnemann Medical University, etc., and served as a visiting professor at Stanford University, University of California, San Francisco, Juntendo University, Nihon University School of Medicine, and Kyorin University School of Medicine.

Professor Hiroyuki Abe has created as many as 9 kinds of combination cells, including polyvalent dendritic cells, active NK cells, active NK T cells, and delta T cells**, which have been patented for this method in many countries and regions, including Japan.

At present, the Tokyo Cancer Center and Adventist Health have reached an official referral agreement, and now through the referral of Adventist Health, you can get the precious opportunity of Professor Hiroyuki Abe, the father of cellular immunity in Japan, to personally see and **, and also coordinate with the Japan Proton and Heavy Ion Hospital to formulate an exclusive tumor joint ** plan, and cooperate with the group's landing service team in Tokyo, Japan, you can enjoy one-stop VIP services for medical treatment in Japan. If you want to know more about Professor Hiroyuki Abe, the father of cellular immunity in Japan, or if you are interested in traveling to Japan to receive this **, please consult Adventist Health.

Professor Hiroyuki Abe has created as many as 9 kinds of combination cells, including polyvalent dendritic cells, active NK cells, active NK T cells, and delta T cells**, which have been patented for this method in many countries and regions, including Japan.

Professor Hiroyuki Abe has created a variety of cellular immunity** combinations by studying the principle of human immune cells killing cancer cells, and has conducted clinical trials** at the Tokyo Cancer Center in Japan.

I just saw on the Internet that Professor Hiroyuki Abe, the father of cellular immunity in Japan, is cooperating with Hong Kong Adventist Health, so you can consider consulting Hong Kong Adventist Health.

Dendritic cells, also known as DC cells, are a type of immune cells that do not directly attack cancer cells, but convey the specificity of cancer cells to T lymphocytes (specificity: normal cells do not have, allowing aggressive immune cells to recognize the antigens of cancer cells), and play the role of issuing instructions, just like a "command tower". In this case, dendritic cells must be infused with cancer antigen (induction) outside the body and then back into the patient.

Dendritic cells give instructions to T cells, which recognize cancer cells and attack them based on the antigenic instructions they receive.

T cells are a method of fully activating and proliferating T cells, which are one of the most cancer-aggressive cells, and returning them to the patient. Because about 95% of T lymphocytes are T cells, this method is called T cells. T cells** are not specific for cancer antigens, and when the patient's cancer antigen cannot be determined, or when the cancer cells themselves hide the cancer antigen within the cell membrane, T cells** can play a role, and are used in a wide range of applications from early to advanced cancers.

Medical studies have shown that most cancer patients have their immune function suppressed by tumors, and T cells** help to relieve the patient's immunosuppressive state. If combined with chemoradiotherapy, increased efficacy can be expected.

T cells can quickly sense and attack cells that have been infected by bacteria or viruses, or cells that have already developed early cancer. At the same time, the content of delta T cells in T lymphocytes is very small, only a few percent, and it is generally difficult to culture in vitro for **, and only a few medical institutions in Japan have the ability to culture them. If you are currently using antibody drugs**, or are using zoledronic acid for myeloma, bone metastases, etc., you can expect better results if you combine delta T cells**.

NK cells (natural killer cells) account for about 10 20% of the content in peripheral blood, and they themselves are cells with powerful cell killing ability. Normally, NK cells "patrol" the human body and attack when they find cancer cells or abnormal cells infected by viruses, which is equivalent to an early attack force in battle. NK cells** are NK cells collected from the patient's body, activated and proliferated in vitro, and then infused back into the patient's body**.

There are 4 types**.

Results vary from person to person.

Immunology** Surgery, chemotherapy, and radiotherapy are the three traditions**.

Beyond that, it's immunity**.

None other than the above four**.

Overseas medical care in the 100-year-old eraIt is believed that making the best use of the above four ** is the key to **.

Immunization is indeed effective, prolonging survival, and is the best choice for patients.

For example, the Japan Cancer Institute, which cooperates with Tamami, has two branches in Japan: Tokyo · Osaka has accumulated a wealth of experience with more than 5,000 cases of various types of cancer.

The process of cellular immunity in Tokyo, Japan**, is to collect immature immune cells (blood) in the patient's body, activate and culture them in the laboratory to make them have the ability to efficiently recognize and kill tumor cells, and then infuse them back into the patient's body. Patients only need to cooperate with the two steps of blood collection and blood transfusion, and do not need to be hospitalized.

Harbor} AnHealthy. Kang said that the advantages of ** are highlighted in:

By collecting human autoimmune cells, the number of them is increased by thousands of times through in vitro culture, and then the targeted killing function of immune cells is enhanced, and then infused back into the human body to kill pathogens, cancer cells, and mutated cells in blood and tissues, break the body's immune tolerance, activate and enhance the body's immunity, and have the dual effects of prevention and treatment.

Cancer Prevention** and Metastasis Choosing Japanese Cells** is very good, Japanese Cells** Cancer Prevention** and metastasis can not only break the body's immune tolerance, but also activate and enhance the immune ability of the receptors. If you want to accept this kind of **, you can consult Hong Kong Adventist Health in advance to understand. They have served a lot of patients who have received this kind of **, and they are still relatively experienced.

Immunization**Applicable population: All cancer patients. As well as combined with surgery, chemotherapy, radiotherapy** or more severe***, immune cells can also be used**.

And Japan has been constantly developing new methods, and some time ago developed new fusions. If it doesn't work, it's impossible to continue researching!

And the average person can prevent tumors if they do immune cells**, these are the last time I heard a friend say that they can help do it, the name is the 100-year-old era, you can search for it.

Immune cells**.

Immune cells** are extracted, cultured and infused to rapidly increase the number of immune cells and achieve the improvement of the body's overall or specific immunity**.

Why go to Japan to do immune cells**.

Immune cells** have been around in Japan for more than 30 years, and Japan was awarded the 2018 Nobel Prize in Physiology or Medicine in this field.

Succeeded in developing a method for activating and proliferating immune cells at the same time, and Japan is leading the world in immune cell technology.

Different from traditional chemoradiotherapy, cellular immunity** is to attack cancer cells in the body by cultivating immune cells in the patient's body, enhance the patient's resistance, and will not affect the patient's own normal cells, which can be done in China at present.

Although cancer can often achieve good results after timely surgery, the probability of metastasis after surgery is very high, so patients should assist others to carry out postoperative surgery to effectively prevent disease metastasis. Tokyo Immune Cells** has significant effects and outstanding advantages in preventing cancer metastasis, and can improve the effect of **, enhance patients' immunity, and improve patients' health status and quality of life. If you need to take the Tokyo Immune Cell****, you can contact An Health at any time for evaluation.

The Tokyo Cancer Center in Japan was founded by Professor Hiroyuki Abe, the father of cell ** in Japan. Professor Hiroyuki Abe has given lectures in the United States, Japan, and Germany. He is also the founder of Cell**.

In Cell**, Professor Hiroyuki Abe is very experienced. If you want to go to Tokyo Cancer Center in Japan, you can choose a medical service platform that cooperates with Tokyo Cancer Center. At present, only Adventist Health has cooperated with Professor Hiroyuki Abe, and if you want to prevent cancer metastasis, you can choose to go to Japan to do cells.

Founded by Professor Hiroyuki Abe, the father of cellular immunity in Japan, Tokyo Cancer Center is the first specialized hospital in Japan recognized by the Ministry of Labor and Health of Japan to specialize in the study of cellular immunity.

To make an appointment to see a doctor at the Tokyo Cancer Center in Japan, it is best to choose a regular overseas medical institution with a personal guarantee qualification. Quiet. Health is good.

The effect of lung cancer biological immunity** should be measured for the content of PDL1. The purpose of tumor immunity** is to stimulate and mobilize the body's immune system, enhance the tumor microenvironment, anti-tumor immunity, and thus control and kill cells. There are now several categories of immunity** against tumors, especially lung cancer

For PDL1 inhibitors and immunoassay inhibitors, the currently domestically marketed durvalumab and atezolizumab for PD1 are pembrolizumab, nivolumab, camrelizumab, sindilil and terprelil. The effect of immunity is mainly to detect the content of PDL1, such as the content of PDL1 TPS is greater than 50%, and the effect of immune checkpoint inhibitors alone is better, such as PDL1 positive, that is, TPS positive in 1 to 49%, the effect of this monotherapy immune checkpoint inhibitor is worse, but if he combines chemotherapy, the effective rate of ORR will be greatly improved, for PDL1 is negative, referring to less than 1% of patients, it is recommended that chemotherapy combined with immunoassay inhibitors, to perform anti-tumor**.

The effect must be there, after all, it won the Nobel Prize in medicine in 2018, which means that the research has been recognized, but the clinical ** has not been fully applied, indicating that it is only applicable to a small number of people, and the ** cost is not acceptable to the general public. A friend of mine was cured by Dr. Duan Ruqin's traditional Chinese medicine, which is very good and affordable, and Dr. Duan Ruqin** has been suffering from lung cancer for many years.

In Japan, immune cells are taken from the patient's blood and cultured in vitro using regenerative medicine technology, and in order to ensure safety, cell culture is performed in a new and safe laboratory environment, and each process of cell culture is checked for sterility. At the same time, it is very safe to check the number of toxins (feverish substances) and cells in the patient's body before giving it back to the patient. According to Adventist Health, Japanese cells** can effectively remove latent and residual cancer cells after surgery, prevent lung cancer** or metastasis, and at the same time enhance chemoradiotherapy tolerance, reduce chemoradiotherapy toxicity***, improve the quality of life of patients, and achieve the best prognostic effect.

Domestic lung cancer immune cells** are used to attack cancer cells with the patient's own immune cells, not normal cells, and can be used in combination with the three major standards**.

After surgery, it can consolidate the curative effect, prevent tumor metastasis, reduce the risk of metastasis, strengthen the effect of radiotherapy and chemotherapy, and can also improve the quality of life of cancer patients, prolong life, etc., and the Japanese NK cell immunity has been approved by the Ministry of Health and Welfare in Japan and is legally used.

The advantages of Japanese NK cell immunity are highlighted: by collecting human autoimmune cells, the number of them is increased by thousands of times through in vitro culture, and then the targeted killing function of immune cells is enhanced, and then infused back into the human body to kill pathogens, cancer cells, and mutated cells in blood and tissues, break the body's immune tolerance, activate and enhance the body's immunity, and have the dual effects of prevention and treatment. If you need to travel to Japan for NK cell immunization**, you can contact Adventist Health for assessment and appointment.

There are them in China, Beilian NK immune cells.

Tumor immune cells** are the application of immunological principles and methods to improve the immunogenicity and sensitivity of tumor cells to effector cell killing, stimulate and enhance the body's anti-tumor immune response, and the use of immune cells and effector molecules to infuse the host body, cooperate with the body's immune system to kill tumors and inhibit tumor growth. In order to achieve the best effect, for cancer, the hospitals of Beilian cooperation have adopted immune cells.